TARO-DASATINIB
TARO-DASATINIB
Approved
DIN Number
02499312
Drug Class
Human
Market Date
Mar 4, 2021
Company
HC
Taro Pharmaceuticals Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02499312
AIG Number0152198003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01EA02 DASATINIB
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
DASATINIBActive
Strength: 70 MG
Monograph: DASATINIB